Assay Protocol (PDF)
*Please Note: For best results, use DPP-IV inhibitor instead of Aprotinin.
Links to publications that use this kit:
Drafts BC, Twomley KM, D'agostino R, et al. Low to Moderate Dose Anthracycline-Based Chemotherapy Is Associated With Early Noninvasive Imaging Evidence of Subclinical Cardiovascular Disease. JACC Cardiovasc Imaging. 2013. doi:10.1016/j.jcmg.2012.11.017.
Fernández-García JC et al, GLP-1 and Peptide YY Secretory Response after Fat Load is Impaired by Insulin Resistance, Impaired Fasting Glucose and Type 2 Diabetes in Morbidly Obese Subjects.Clin Endocrinol (Oxf). 2013 Apr 11. doi: 10.1111/cen.12221. [Epub ahead of print]
Minako Yamaoka-Tojo et al., Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular diseaseCardiovascular Diabetology 2010, 9:17 doi:10.1186/1475-2840-9-17
Granata et al. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes. 2008 Apr;57(4):967-79.
Santoro et al. Enterohormonal changes after digestive adaptation: five-year results of a surgical proposal to treat obesity and associated diseases. Obes Surg. 2008 Jan;18(1):17-26.
Pacheco et al. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats.Am J Surg. 2007 Aug;194(2):221-4.
Suzuki et al. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat modelSurgery. 2005 Aug;138(2):283-90.
